Super-Enhancers Damage Cancer's Own DNA
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Osama Hidmi and Prof. Rami Aqeilan at the Hebrew University of Jerusalem published findings in Science Advances identifying super-enhancers as hotspots for double-strand DNA breaks in cancer cells.
- Genome-mapping analysis revealed DNA breaks clustered inside genes controlled by super-enhancers rather than scattering randomly throughout the cancer genome.
- Cancer cells repeatedly damage and repair DNA in these intensely active regions, with each repair cycle introducing small errors that let mutations accumulate over time.
- Researchers said accumulating mutations in super-enhancer-driven genes may help tumors spread, withstand stress, and become less responsive to treatment.
- The team concluded that genetic instability in cancer may emerge directly from the intense gene activity tumors need to keep growing — not merely as a side effect.
- The proposed therapeutic angle: because tumors depend on these high-stress regions, future treatments could disrupt super-enhancer-driven activity or block the DNA-repair machinery cancer cells rely on at those break hotspots.
Why it matters: For cancer researchers and drug developers, the finding reframes super-enhancers from pure growth drivers into structural vulnerabilities — the very regions where tumors are most active are also where their DNA is most fragile. That points to two concrete intervention paths: disrupting super-enhancer-driven transcription or blocking repair at the break hotspots that cancer cells cannot easily do without.
